Zytoprotec Secures Funds from Baxter Ventures
Zytoprotec, a company developing novel peritoneal dialysis solutions and other treatments based on active cytoprotection, has raised 2 million euros ($2.7 million) from new investor Baxter Ventures. The funding goes towards a 4 million euros Series A financing.
29 January 2013•3 mins read
